Microsoft PowerPoint - AVNT Q2 2021 Earnings Presentation - Website AVIENT CORPORATION S E C O N D Q U A R T E R 2 0 2 1 R E S U LT S (NYSE: AVNT) J U LY 3 0 , 2 0 2 1 DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. D is t. ) K W R P P G A V Y F U L R P M G C P H X L F M C H U N IF F E C L A S H K R A E M N C E S C L A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of July 28, 2021 Avient reflects 2021 estimated revenue of $4,650M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 25 Avient reflects 2021 estimated EBITDA of $580M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 9.5 18.5 15.1 15.1 14.0 11.0 10.4 29.5 28.2 23.9 18.7 12.4 12.2 11.1 9.3 9.2 9.2 7.6 7.6 6.0 A vi en t K W R P P G A V Y R P M F U L G C P A L B H X L E C L IF F F M C B N R A S H S C L E M N U N V R K R A C E H U N Median: 11.1xMedian: 14.6x SUMMARY: WHY INVEST IN AVIENT?

Microsoft PowerPoint - Avient Q1 2021 Earnings - Final (For Print) AVIENT CORPORATION F I R S T Q U A R T E R 2 0 2 1 R E S U LT S (NYSE: AVNT) A P R I L 3 0 , 2 0 2 1 DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. D is t. ) K W R R P M P P G A V Y F U L G C P IF F H X L F M C F O E H U N E C L K R A E M N A S H C E S C L G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of April 27, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 20 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 10.2 17.7 16.0 14.9 14.6 11.6 11.1 26.7 24.0 22.8 14.3 12.7 11.5 11.2 11.1 11.0 10.3 10.1 9.5 9.4 8.3 7.0 A vi en t K W R A V Y R P M P P G G C P F U L A L B H X L E C L IF F F M C B N R A S H G R A F O E S C L E M N U N V R C E K R A H U N Median: 11.1xMedian: 14.8x SUMMARY: WHY INVEST IN AVIENT?

TIER 1 SUPPLIER S E A T B U C K L E S Y S T E M • Rapid development of 3 colors for global OEM platform, for 3 materials (POM, SAN, PP) • Help Tier 1 transition from printing to laser marking of buckles • Develop formulation that offers laser marking solution plus color • Quick reaction to develop three colors for this global vehicle launch • Smartbatch™ color + laser marking formulation met requirements for critical safety components Smartbatch™ Combination Colorants & Additives KEY REQUIREMENTS WHY AVIENT?

SURGICAL DEVICE MANUFACTURER H A N D L E H O U S I N G F O R L A P A R O S C O P I C S E A L E R • Excellent adhesion onto PC/ABS • Good aesthetics with soft touch • RoHS, REACH and FDA compliant • Enhanced ergonomics and functionality with improved soft grip • Met performance requirements for wear resistance and colorability • Customized a thermoplastic elastomer (TPE) solution and had with a faster sample response speed than competitor Versaflex™ Overmolding Formulation KEY REQUIREMENTS WHY AVIENT?

PHARMACEUTICAL PACKAGING OEM V I A L S , B O T T L E S & C O N T A I N E R S • Raw materials pre-tested to USP 661.1 and ICHQ3D guidelines • Stabilization during molding and sterilization processes for both opaque and transparent polymer materials • Certified formulations available globally • Offered pre-tested raw materials and produced in an ISO 13485 certified site, minimizing risk across the pharmaceutical value chain • Delivered specialized formulated solutions to meet stringent pharmaceutical packaging requirements • Provided global formulations transferrable from our three ISO 13485 certified facilities Mevopur™ Healthcare Concentrates KEY REQUIREMENTS WHY AVIENT?

Complet LFT - Trail Bicycle Suspension Link PERFORMANCE CYCLING OEM T R A I L B I C Y C L E S U S P E N S I O N L I N K • Weight reduction to reduce cyclist fatigue • Structural strength and toughness capability • Endure repeated piston actions during use • Replaced aluminum to reduce weight 33% • Optimized design for metal-to-thermoplastic conversion • Conducted FEA performance analysis to confirm composite met specifications Complēt™ Long Carbon Fiber ETPU Composite KEY REQUIREMENTS WHY AVIENT?

FAMOUS TIER 2 COMPANY A U T O M O T I V E L I G H T I N G I R L E N S O F S E N S O R • High heat resistance up to 203°C • PESU base resin with high IR transmission • Visible light cannot pass through • Used rich experience with different IR transmission materials to support customer’s material design and test method • Customized color for IR transmittance, which allowed IR to pass through the plastic lamp without accumulating high heat Edgetek™ ET9400-8005 IR Formulation KEY REQUIREMENTS WHY AVIENT?

AVIENT SOLUTION SWIMMING GEAR BRAND S W I M G O G G L E G A S K E T A N D N O S E B R I D G E • Bio-content material • Good adhesion to PC • Flexible and comfortable to wear • Easy to process • Customized formulations for a transparent Shore 43A TPE with 40% bio-based content for the gasket and a natural 57A TPE with 30% bio-based content for the nose bridge to meet sustainability and comfort targets • Delivered excellent performance in order to pass strict chlorine, brine, and QUV tests • Offered prompt development and on-site technical services to accelerate commercialization KEY REQUIREMENTS SUSTAINABILITY + SEALING LEARN MORE reSoundTM BIO Thermoplastic Elastomers Copyright © 2022, Avient Corporation.

PERSONAL CARE PRODUCTS MANUFACTURER B O T T L E S A N D C L O S U R E S • Achieve a lower cost on low volume orders • Accommodate a large number of custom designs with rapid color development and matching • Gain quick turnaround for colorant orders • Offered flat pricing with a minimum order quantity (MOQ) of 10 pounds • Eliminated low-volume surcharges, driving leaner inventory management • Implemented shorter development lead times to enable faster market access • Provided 3-day order lead times ColorMatrix™ Small Order Service KEY REQUIREMENTS WHY AVIENT?

Medical textile manufacturer LEARN MORE MEDICAL TEXTILE MANUFACTURER S U R G I C A L D R A P E S & G O W N S • Pre-tested for ISO 10993 biocompatibility standard • Available in standard blue or other customized colors • Compatible with ETO sterilization • Suitable for use in non-woven SMS spunbond layer • Offered standard blue and custom colors such as green • Pre-tested raw materials for biocompatibility ISO10993 standard • Manufactured under ISO 13485 certified medical sites with change control in place MevopurTM Healthcare Colorants and Formulations KEY REQUIREMENTS WHY AVIENT?